Over the last 12 months, the cell and gene therapy manufacturing sphere has matured vastly with more companies advancing to commercial products, especially with allogenic therapies. Now that the theory behind the therapy is catching up with the technology, the two can come together to progress towards producing commercial products.
In this Cell and Gene Manufacturing hotspot map, we have broadened our focus to scan the cell and gene manufacturing activity that is occurring across Europe regarding the road to commercialised therapies.
Please note: That all fields marked with an asterisk (*) are required.
*Processing your payment may take a moment. Please click submit payment only once, and do not refresh this page. Doing so may result in your credit card being charged more than once.
Your experience on this site will be improved by allowing cookies.